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Abstract                 
Introduction: To investigate 28 days survival rate following first acute myocardial infarction 
(AMI) associated with the presence of classical risk factors and treatment modalities in 
Gorgan, north of Iran. 
Materials and methods: Our cohort including all patients hospitalized due to AMI from 
2010 to 2013. Data were collected on demographic, prophylactic drugs and classical coronary 
risk factors. Data were analyzed using Kaplan-Meier and log rank tests. Cox proportional 
hazard model was built to estimate relative risk by taking into account other variables. 
Results: Median age of subjects was 58 and 64 for men and women, respectively; moreover, 
the occurrence of diabetes was 52.5 and 24.5 for them. A poorer outcome was detected in 
survival rate for women in the final model. Excess death occurrence in Fars or non- Persian 
ethnicity, and those who were not prescribed statin was detected in the adjusted model. 
Conclusion: A better survival rate for those who were prescribed statin suggest that it could 
be beneficial in treatment modality and non-Persian ethnicities needed to be considered as a 
group of at risk for earlier screening programs. In spite of some other studies a poorer 
outcome following AMI for women was found even after taking into account age and 
comorbidity. 
Keywords: Acute myocardial infarction, Survival, Risk factor, Treatment 
Introduction 
Cardiovascular disease is the first leading 
cause of death, and its burgeoning growth 
is more likely to be found in low and 
mediocre income countries (1). In many 
developed countries, death rate from 
coronary heart disease has been steadily 
declining which has been attributed to 
factors such as decreasing in incidence, 
increasing the short term survival after 
hospitalization and also improvement in 
treatment. The development of national 
registries in some countries is beginning to 
reveal the nature of coronary heart disease. 
Improving lifestyles (reducing calorie 
intake and increasing physical activity) in 
patients in the region will be essential, 
although cultural and environmental 
barriers will render this difficult. 
Appropriate prescribing of pharmacologic 
treatments is essential in the prevention 
and management of cardiovascular 
disease. In particular, recent controversies 
relating to the therapeutic profile of beta-
blockers may have reduced their use. The 
current evidence base suggests that beta-
blockers are as effective as other therapies 
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in preventing cardiovascular disease and 
that concerns relating to their use in 
hypertension and cardiovascular disease 
have been overstated. (2-4).  
Cardiovascular disease and its associated 
risk factor such as, hypertension, diabetes 
mellitus are placed among top ten diseases, 
according to a DALY index in Iranian 
communities (5), which can incurred a 
heavy burden on patients and society. 
the prevalence of coronary heart disease is 
promoted in turn by a high prevalence of 
cardiovascular risk factors, particularly 
smoking, hypertension, dyslipidemia, 
diabetes, and sedentary lifestyles previous 
history of myocardial infarction (6), age 
and gender has introduced as a risk factor 
for coronary heart disease (6, 7). In 
addition to these factors, Griffiths and 
colleagues have stated among secondary 
prophylactic drugs, statin are related to 
survival rate and no significant association 
was found for those who had been 
prescribed thrombolytic (2). However, 
some studies have been shown the positive 
beneficial effect of thrombolytic therapy 
on acute myocardial infarction (AMI) (8, 
9).  
Despite a significant reduction in 
incidence of coronary disease in various 
countries (3, 10, 11) and advances in the 
treatment methods and appliances (12-14), 
the case fatality rate resulting from acute 
myocardial infarction has remained high in 
both sexes Most but not all studies suggest 
that women are less likely to develop 
coronary heart disease than men but are 
more likely to die when they do. Many 
reasons have been advanced to explain this 
observation. Women tend to be older than 
men at the time of their myocardial 
infarction (15).  
The aim of this study was to investigate 28 
days survival rate following first acute 
myocardial infarction and the effect of 
classical coronary risk factors (e.g.; 
hypertension, diabetes, etc.) and receiving 
secondary prophylactic drugs, including 
ACE inhibitors, B blocker, statin, Aspirin 
and uptake of thrombolysis on acute 
myocardial infarction. 
Materials and methods 
This study was confirmed by the Ethics 
Committee of the Golestan University of 
Medical Science.The subjects of our 
cohort consisted of all patients were 
hospitalized, in all public, educational and 
private hospitals, owing to First AMI in 
Gorgan, north of Iran from 2010 to 2013. 
Data were collected on gender, age at 
diagnosis, the presence of acute 
myocardial risk factors (diabetes, 
hypertension, ischemic heart disease, 
smoking or being addicted, previous or 
family history of heart attack, AMI 
characteristics including inferior or 
anterior stroke, treatment including ACE, 
Beta blocker, Thrombolytic, Aspirin and 
statin. All subjects were contacted by 
phone, and information on their current 
status and patients medical recording were 
also collected by trained interviewers.  
Information was collected from close 
relatives in cases who had passed away. 
Follow-up period was taken considered 28 
days after emerging the first medical 
symptoms of myocardial infarction, 
including symptoms, electrocardiogram 
and abnormal enzyme (16, 17). No data 
were collected on those who could not be 
followed (e.g., those who had left their 
place). Death due to accident, Chronic 
obstructive pulmonary disease, cancer, 
Liver and kidney diseases, Cardio- 
vascular diseases except for coronary, 
without any kind of coronary disease or 
Atherosclerosis at the first attack during 28 
days or lost to follow-up, were considered 
as censor.  
Kaplan-Meier and log rank tests were used 
to compare median survival rate. Cox 
proportional hazard models were built to 
estimate the patient’s survival rate. The 
proportional hazard assumption was 
verified by log minus log approach. P 




































    
    



















We analyzed 413 Patients from AMI in 
our cohort. The mean age at diagnosis was 
58.4 ± 12.7 and 63.7 ± 11.2, respectively, 
with a male to female ratio of 1.96. 
Overall 48 deaths were identified among 
these cases, 17 of which were men and 31 
of which were women. 20 (4.8%) Deaths 
were identified due to other disease. The 
average follow-up time was 26.89 ± 0.35 
days. The occurrence of diabetes was 24.5 
and 52.5 for men and women, respectively 
(Table 1). 
  
Table 1.  Demographic and clinical feature of acute myocardial infarction subjects. 
Variables  Male Female Both sexes 
Demographic 
Residency  
Urban  200 (73.5) 94 (68.6) 294(61.9) 
Rural  72 (26.5) 43 (31.4) 115 (38.1) 
Ethnicity 
Fars or Persian  163 (90.1) 77 (83.7) 240 (87.9) 
Turkmen  7 (3.9) 9 (9.8) 16 (5.9) 
Sistani   11(6.1) 6 (6.5) 17 (6.2) 
Medical history    
Diabetic  
Yes 67 (24.5) 73 (52.5) 140 (33.9) 
No 207 (75.5) 66 (47.5) 273 (66.1) 
Hypertension  
Yes 99 (36.1) 77 (55.4) 176 (42.6) 
No 175 (63.9) 62 (44.6) 237 (57.4) 
IHD 
Yes 54 (19.7) 25 (18) 79 (19.1) 
No 220 (80.3) 114 (82) 334 (80.9) 
Previous history  
Yes 48 (26.2) 20 (25) 68 (25.9) 
No 135 (73.8) 60 (75) 195 (74.1) 
Family history  
Yes 63 (34.6) 21 (25.3) 84 (31.7) 
No 119 (65.4) 62 (74.7) 181 (68.3) 
Smoking  
Yes 120 (51.3) 77 (75.5) 197 (58.6) 
No 114 (48.7) 25 (24.5) 139 (41.4) 
Addicted  
Yes 105 (43.4) 27 (26) 132 (38.2) 
No 137 (56.6) 77 (74) 214 (61.8) 
Characteristic  
Stroke 
Inferior 114 (54.8) 42 (44.7) 156 (51.7) 
Anterior 94 (45.2) 52 (55.3) 146 (48.3) 
Treatment  
ACE 
Yes 118 (43.2) 55 (39.6) 173 (42) 
No 155 (56.8) 84 (60.4) 239 (58) 
Beta blocker  
Yes 164 (60.1) 92 (66.2) 256 (62.1) 
No 109 (39.9) 47 (33.8) 156 (37.9) 
Thrombolysis  
Yes 197 (72.2) 82 (59.4) 279 (67.9) 
No 76 (27.8) 56 (40.6) 132 (32.1) 
Asprine  
Yes 246 (90.1) 121 (87.1) 367 (89.1) 
No 27 (9.9) 18 (12.9) 45 (10.9) 
Statin  
Yes 227 (83.2) 113 (81.3) 340 (82.5) 
No 46 (16.8) 26 (28.7) 72 (17.5) 
Status  
Death 17 (6.2) 31(22.3) 48 (11.6) 
Alive 241(88) 104 (74.8) 345 (83.5) 
Other 16 (5.8) 4 (2.9) 20 (4.8) 
Data are shown as number (percent).  
Univariate analysis indicated a higher 
significant survival rate for cases receiving 
treatment, including ACE inhibitor, Beta 
blocker and Aspirin. No significant 
association was found in survival rate for 
thrmbolysis. There was no difference 
observed in survival rate of diabetes, 
ischemic heart disease, smoking or 
addicted patients. The survival rate in 
patients with hypertension was 
significantly lower than in those who had 
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Table 2. Classical coronary risk factors, secondary prophylactic drugs and receiving thrombolysis on acute 
myocardial survival, unadjusted Cox regression model for time to death. 
Demographic Variables Number of deaths Unadjusted HR 
Age  Continuous - 1.06 (1.04-1.09)** 
Gender  
Male 17 1 
Female 31 3.72 (2.05-6.72)*** 
Residency  
Urban 28 1 
Rural 19 1.78 (0.99-3.18) 
Ethnicity 
Fars or Persian 18 1 
Non-Persian 
(Sistani/Turkmen) 
6 2.59 (1.03-6.53)* 
Medical history 
Diabetic  
Yes 22 1.69 (0.96-2.98) 
No 26 1 
Hypertension  
Yes 27 1.78 (1.007-3.15)* 
No 21 1 
IHD 
Yes 13 1.61 (0.85-3.05) 
No 35 1 
Smoking  or addicted 
Yes 13 1.27 (0.41-3.88) 
No 4 1 
Treatment  
ACE Yes 11 1 
 No 36 2.52 (1.28-4.94)* 
Beta blocker  
Yes 22 1 
No 25 1.89 (1.07-3.36)* 
Thrombolysis  
Yes 27 1 
No 20 1.65 (0.93-2.94) 
Aspirin  
Yes 36 1 
No 11 2.66 (1.35-5.22)** 
Statin  
Yes 31 1 
No 16 2.61 (1.43-4.78)* 
* P<0.05    ** P<0.01    *** P<0.001 
After adjusting for potential confounders 
including age at diagnosis, gender, 
ethnicity, treatment (ACE inhibitor, Beta 
blocker, Aspirin), and hypertension, 
patients who did not receive statin were 
3.07 (95% CI=1. 33-7.13) times more 
likely to die compared to those receiving 
statin (Table 3). The multiple cox 
regression models detected that mortality 
rate No serious violations of proportional 
hazard assumptions were observed after 
checking the model. 
Table 3. Factors associated with survival in adjusted Cox regression model for time to death. 
Variables Category Adjusted HR Confidence interval 
Age Continuous 1.08 1.03-1.13 *** 
Gender 
Male   
Female 3.77 1.54-9.22 ** 
Ethnicity 
Fars or Persian   
Non- Persian (Sistani or Turkmen) 2.66 1.03-6.87 * 
Statin 
Yes   
No 3.07 1.33-7.13 ** 
* P<0.05     ** P<0.01     *** P<0.001 
Discussion  
We found that receiving statins was the 
most important independent predictor 
significantly associated with survival 
among acute myocardial infarction 
patients. Ethnicity, age and gender also 
significantly related to survival by taking 
into consideration others potential 
confounders.  
Our finding showed a better survival for 
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showed that older age and comorbidity are 
associated to lower survival in women, and 
no relationship was reported between 
therapeutic modalities, invasive coronary 
procedures and sex difference mortality 
(18). The higher mortality rate in women 
during 28 days after AMI has been shown 
in some other studies (19, 20). 
Moreover, the excess mortality rate in men 
on arrival lead to have been estimated 
higher survival for them following 
hospitalization than women (5, 21, 22). So, 
the gender differences might be derived 
from a selection bias. According to this, 
long term survival can be a better 
estimation to perceive the effect of gender 
on survival rate. MacIntyre and colleagues 
was detected no association between 
gender and long term survival (21). 
Herman and colleagues also stated the 
excess death occurrence in women is 
owing to confounders such as, age and 
treatment modality, in acute myocardial 
infarction (23). Nonetheless, in our study, 
a significant better survival was detected 
for women by taking into account 
aforementioned potential confounders 
including, age at diagnosis, diabetes, 
hypertension, treatment modality, etc. 
which is in accordance with some other 
studies (19, 24). 
It should be noticed that women were 
more smoker compared to men in the 
present survey, and in addition to being 
older, women were more diabetic, which 
raising the probability that women are 
more susceptible to have poorer outcome 
following AMI. Race/ethnicity have been 
considered for evaluating socioeconomic 
status (25, 26) and higher mortality rate 
following acute myocardial infarction has 
been reported for deprived groups (27-29). 
Our results detected an excess mortality 
rate in Turkmen and Sistani ethnicity 
compared to Fars ethnicity. 
Socioeconomic inequality is an important 
issue between person (Fars) and non- 
Persian population in Iran (30) which has 
been introduced, socioeconomic 
inequality, as a major factors in AMI (27). 
It might be argued that Turkmen and 
Sistani population, as non- Persian 
communities, are considered as a deprived 
group compared to Fars communities. In 
addition, one study indicated nearly 60% 
and 25% of the Turkmen population were 
overweight and obesity, respectively, 
which explain the excess death occurrence 
of them (31). Our data were detected an 
excess mortality rate for those who were 
not prescribed statins, and there were no 
association between prescription of ACE 
inhibitor, B blocker, Aspirin, with survival 
rate which in accordance with the study of 
Griffith and colleague (2). The advantages 
of thrombolytic therapy and its safety were 
detected in some studies (8, 9), however; 
no association was found in the current 
research with survival rate, which is in line 
with some national (19) and international 
studies (2). No significant association 
between location of myocardial infarction 
and survival rate, which is accordance with 
Lenderink and colleague (32) However 
some studies have shown that mortality  
rate are different based on myocardial 
infarction location, as patients are more 
likely to die with anterior MI (19, 33). A 
survey that conducted by hafshejani and 
colleague showed the probability of death 
is 4.2 in subject with anterior MI 
compared to inferior MI (19). 
Conclusion  
A better survival rate for those who were 
prescribed statin suggest that it could be 
beneficial in     treatment modality and 
non-Persian ethnicities needed to be 
considered as a group of at risk for earlier 
screening programs. In spite of some other 
studies a poorer outcome was found 
following AMI for women even after 
taking into account age and comorbidity.  
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